Detailed TOC of Global NK Cell Therapy Market Research Report 2025
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2019 VS 2025 VS 2033
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global NK Cell Therapy Market Growth by Application: 2019 VS 2025 VS 2033
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NK Cell Therapy Market Perspective (2019-2033)
2.2 NK Cell Therapy Growth Trends by Region
2.2.1 Global NK Cell Therapy Market Size by Region: 2019 VS 2025 VS 2033
2.2.2 NK Cell Therapy Historic Market Size by Region (2019-2025)
2.2.3 NK Cell Therapy Forecasted Market Size by Region (2025-2033)
2.3 NK Cell Therapy Market Dynamics
2.3.1 NK Cell Therapy Industry Trends
2.3.2 NK Cell Therapy Market Drivers
2.3.3 NK Cell Therapy Market Challenges
2.3.4 NK Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NK Cell Therapy Players by Revenue
3.1.1 Global Top NK Cell Therapy Players by Revenue (2019-2025)
3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2019-2025)
3.2 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NK Cell Therapy Revenue
3.4 Global NK Cell Therapy Market Concentration Ratio
3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2025
3.5 NK Cell Therapy Key Players Head office and Area Served
3.6 Key Players NK Cell Therapy Product Solution and Service
3.7 Date of Enter into NK Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NK Cell Therapy Breakdown Data by Type
4.1 Global NK Cell Therapy Historic Market Size by Type (2019-2025)
4.2 Global NK Cell Therapy Forecasted Market Size by Type (2025-2033)
5 NK Cell Therapy Breakdown Data by Application
5.1 Global NK Cell Therapy Historic Market Size by Application (2019-2025)
5.2 Global NK Cell Therapy Forecasted Market Size by Application (2025-2033)
6 North America
6.1 North America NK Cell Therapy Market Size (2019-2033)
6.2 North America NK Cell Therapy Market Growth Rate by Country: 2019 VS 2025 VS 2033
6.3 North America NK Cell Therapy Market Size by Country (2019-2025)
6.4 North America NK Cell Therapy Market Size by Country (2025-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NK Cell Therapy Market Size (2019-2033)
7.2 Europe NK Cell Therapy Market Growth Rate by Country: 2019 VS 2025 VS 2033
7.3 Europe NK Cell Therapy Market Size by Country (2019-2025)
7.4 Europe NK Cell Therapy Market Size by Country (2025-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NK Cell Therapy Market Size (2019-2033)
8.2 Asia-Pacific NK Cell Therapy Market Growth Rate by Region: 2019 VS 2025 VS 2033
8.3 Asia-Pacific NK Cell Therapy Market Size by Region (2019-2025)
8.4 Asia-Pacific NK Cell Therapy Market Size by Region (2025-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NK Cell Therapy Market Size (2019-2033)
9.2 Latin America NK Cell Therapy Market Growth Rate by Country: 2019 VS 2025 VS 2033
9.3 Latin America NK Cell Therapy Market Size by Country (2019-2025)
9.4 Latin America NK Cell Therapy Market Size by Country (2025-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NK Cell Therapy Market Size (2019-2033)
10.2 Middle East & Africa NK Cell Therapy Market Growth Rate by Country: 2019 VS 2025 VS 2033
10.3 Middle East & Africa NK Cell Therapy Market Size by Country (2019-2025)
10.4 Middle East & Africa NK Cell Therapy Market Size by Country (2025-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Detail
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics NK Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2019-2025)
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Detail
11.2.2 Innate Pharma SA Business Overview
11.2.3 Innate Pharma SA NK Cell Therapy Introduction
11.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2019-2025)
11.2.5 Innate Pharma SA Recent Development
11.3 Affimed
11.3.1 Affimed Company Detail
11.3.2 Affimed Business Overview
11.3.3 Affimed NK Cell Therapy Introduction
11.3.4 Affimed Revenue in NK Cell Therapy Business (2019-2025)
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Detail
11.4.2 Chipscreen Biosciences Business Overview
11.4.3 Chipscreen Biosciences NK Cell Therapy Introduction
11.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2019-2025)
11.4.5 Chipscreen Biosciences Recent Development
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Detail
11.5.2 Fate Therapeutics Business Overview
11.5.3 Fate Therapeutics NK Cell Therapy Introduction
11.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2019-2025)
11.5.5 Fate Therapeutics Recent Development
11.6 Glycostem Therapeutics
11.6.1 Glycostem Therapeutics Company Detail
11.6.2 Glycostem Therapeutics Business Overview
11.6.3 Glycostem Therapeutics NK Cell Therapy Introduction
11.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2019-2025)
11.6.5 Glycostem Therapeutics Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Detail
11.7.2 Dragonfly Therapeutics Business Overview
11.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction
11.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2019-2025)
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Detail
11.8.2 Kiadis Pharma Business Overview
11.8.3 Kiadis Pharma NK Cell Therapy Introduction
11.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2019-2025)
11.8.5 Kiadis Pharma Recent Development
11.9 NantWorks
11.9.1 NantWorks Company Detail
11.9.2 NantWorks Business Overview
11.9.3 NantWorks NK Cell Therapy Introduction
11.9.4 NantWorks Revenue in NK Cell Therapy Business (2019-2025)
11.9.5 NantWorks Recent Development
11.10 Nkarta Therapeutics
11.10.1 Nkarta Therapeutics Company Detail
11.10.2 Nkarta Therapeutics Business Overview
11.10.3 Nkarta Therapeutics NK Cell Therapy Introduction
11.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2019-2025)
11.10.5 Nkarta Therapeutics Recent Development
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Detail
11.11.2 Fortress Biotech Business Overview
11.11.3 Fortress Biotech NK Cell Therapy Introduction
11.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2019-2025)
11.11.5 Fortress Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
